Entries of Engenhart-Cabillic, R. on the publication server

Dapper, H., Belka, C., Bock, F., Budach, V., Budach, W., Christiansen, H., Debus, J., Distel, L., Dunst, J., Eckert, F., Eich, H., Eicheler, W., Engenhart-Cabillic, R., Fietkau, R., Fleischmann, D. F., Frerker, B., Giordano, F. A., Grosu, A. L., Herfarth, K., Hildebrandt, G., Kaul, D., Kölbl, O., Krause, M., Krug, D., Martin, D., Matuschek, C., Medenwald, D., Nicolay, N. H., Niewald, M., Oertel, M., Petersen, C., Pohl, Fabian, Raabe, A., Rödel, C., Rübe, C., Schmalz, C., Schmeel, L. C., Steinmann, D., Stüben, G., Thamm, R., Vordermark, D., Vorwerk, H., Wiegel, T., Zips, D. and Combs, S. E. (2021) Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations. Strahlentherapie und Onkologie 198 (1), pp. 1-11.

Kuhnt, T., Schreiber, A., Pirnasch, A., Hipp, M., Hass, P., Sieker, F., Engenhart-Cabillic, R., Richter, M., Delias, K. and Dunst, J. (2011) 8501 ORAL Phase ll-trial of Concomitant Hyperfractionated-accelerated Radiotherapy (HART) With Cisplatin (Cis) Plus Cetuximab (Cet) for Locoregionally Advanced Inoperable Squamous Cell Head and Neck Cancer – Early Response and Acute Toxicities. European Journal of Cancer 47, S543. Fulltext not available.